Acronis DeviceLock DLP vs SealPath: Side-by-Side Comparison (2026)

Acronis DeviceLock DLP: Endpoint DLP solution for discovering, protecting, and monitoring sensitive data. built by Acronis International GmbH. Core capabilities include Endpoint data loss prevention controls, USB device control and allowlisting, Network protocol and application controls..

SealPath: Document-level encryption and access control with native app integration. built by SealPath. Core capabilities include Transparent file encryption (open protected files with a double-click, no manual decryption needed), Granular access permissions (read-only, edit, print, extract content) per user, Access tracking and audit logs showing who accessed documents and when..

Both serve the Data Loss Prevention market but differ in approach, feature depth, and target audience.

Acronis DeviceLock DLP differentiates with Endpoint data loss prevention controls, USB device control and allowlisting, Network protocol and application controls. SealPath differentiates with Transparent file encryption (open protected files with a double-click, no manual decryption needed), Granular access permissions (read-only, edit, print, extract content) per user, Access tracking and audit logs showing who accessed documents and when.

Acronis DeviceLock DLP is developed by Acronis International GmbH. SealPath is developed by SealPath. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

Acronis DeviceLock DLP integrates with Active Directory, Group Policy, Microsoft RDS, Citrix XenDesktop, Citrix XenApp and 6 more. SealPath integrates with Microsoft Office, Microsoft 365, SharePoint, Box, Google Workspace (G-Suite) and 10 more. Check integration compatibility with your existing security stack before deciding.

Acronis DeviceLock DLP and SealPath serve similar Data Loss Prevention use cases: both are Data Loss Prevention tools. Review the feature comparison above to determine which fits your requirements.